Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis
- 1 May 2011
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 24 (5), 708-719
- https://doi.org/10.1038/modpathol.2010.238
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mutation analysis of the MSMB gene in familial prostate cancerBritish Journal of Cancer, 2009
- Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancerHuman Genetics, 2009
- Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibilityProceedings of the National Academy of Sciences of the United States of America, 2009
- Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskHuman Molecular Genetics, 2009
- Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancerBreast Cancer Research, 2008
- Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast CancerClinical Cancer Research, 2008
- Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactionsGenome Biology, 2008
- Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical ProstatectomyClinical Cancer Research, 2007
- A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesisInternational Journal of Cancer, 2005
- β-Microseminoprotein binds CRISP-3 in human seminal plasmaBiochemical and Biophysical Research Communications, 2005